These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24458202)

  • 21. Dexamethasone intravitreal implant for treatment of persistent macular oedema in Birdshot retinochoroidopathy.
    Rivera de Zea P; García-Ben A; Rachwani Parshotam N; García-Campos JM
    Arch Soc Esp Oftalmol; 2016 Mar; 91(3):138-41. PubMed ID: 26703205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unilateral intravitreal dexamethazone implant for bilateral retinitis pigmentosa-related macular edema.
    Alhassan M; Quintyn JC
    Graefes Arch Clin Exp Ophthalmol; 2013 Dec; 251(12):2827-8. PubMed ID: 23982775
    [No Abstract]   [Full Text] [Related]  

  • 23. Comments on Letter to the Editor "Unilateral intravitreal dexamethazone implant for bilateral retinitis pigmentosa-related macular edema".
    Querques G; Srour M; Souied EH
    Graefes Arch Clin Exp Ophthalmol; 2013 Dec; 251(12):2829. PubMed ID: 23996148
    [No Abstract]   [Full Text] [Related]  

  • 24. Dexamethasone Intravitreal Implant Injection in Eyes with Comorbid Hypotony.
    Kong X; Psaras C; Stewart JM
    Ophthalmol Retina; 2019 Nov; 3(11):993-997. PubMed ID: 31371197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A meta-analysis of the effect of a dexamethasone intravitreal implant versus intravitreal anti-vascular endothelial growth factor treatment for diabetic macular edema.
    He Y; Ren XJ; Hu BJ; Lam WC; Li XR
    BMC Ophthalmol; 2018 May; 18(1):121. PubMed ID: 29784048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Efficacy of a Dexamethasone Implant for the Treatment of Refractory Cystoid Macular Oedema in Non-Infectious Uveitis].
    Breitbach M; Rack D; Dietzel M; Heinz C; Heiligenhaus A
    Klin Monbl Augenheilkd; 2016 May; 233(5):601-5. PubMed ID: 27187880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dexamethasone intravitreal implant in the treatment of persistent uveitic macular edema in the absence of active inflammation.
    Cao JH; Mulvahill M; Zhang L; Joondeph BC; Dacey MS
    Ophthalmology; 2014 Oct; 121(10):1871-6. PubMed ID: 24907061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bilateral intravitreal dexamethasone implant for retinitis pigmentosa-related macular edema.
    Saatci AO; Selver OB; Seymenoglu G; Yaman A
    Case Rep Ophthalmol; 2013 Jan; 4(1):53-8. PubMed ID: 23616764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravitreal Sustained-Release Steroid Implants for the Treatment of Macular Edema following Surgical Removal of Epiretinal Membranes.
    Hattenbach LO; Springer-Wanner C; Hoerauf H; Callizo J; Jungmann S; Brauns T; Fulle G; Eichel S; Koss MJ; Kuhli-Hattenbach C
    Ophthalmologica; 2017; 237(4):232-237. PubMed ID: 28463851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: the BEVORDEX study.
    Gillies MC; Lim LL; Campain A; Quin GJ; Salem W; Li J; Goodwin S; Aroney C; McAllister IL; Fraser-Bell S
    Ophthalmology; 2014 Dec; 121(12):2473-81. PubMed ID: 25155371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative evaluation of hard exudates in diabetic macular edema after short-term intravitreal triamcinolone, dexamethasone implant or bevacizumab injections.
    Shin YU; Hong EH; Lim HW; Kang MH; Seong M; Cho H
    BMC Ophthalmol; 2017 Oct; 17(1):182. PubMed ID: 28974211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of dexamethasone intravitreal implant (Ozurdex) for the treatment of persistent macular edema secondary to retinal vein occlusion in eyes previously treated with anti-vascular endothelial growth factors.
    Tservakis I; Koutsandrea C; Papaconstantinou D; Paraskevopoulos T; Georgalas I
    Curr Drug Saf; 2015; 10(2):145-51. PubMed ID: 25092480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravitreal dexamethasone implant for the treatment of macular edema after retinal vein occlusion in a clinical setting.
    Ferrini W; Ambresin A
    Klin Monbl Augenheilkd; 2013 Apr; 230(4):423-6. PubMed ID: 23629796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema.
    Castro-Navarro V; Cervera-Taulet E; Navarro-Palop C; Monferrer-Adsuara C; Hernández-Bel L; Montero-Hernández J
    BMC Ophthalmol; 2019 Jan; 19(1):15. PubMed ID: 30634940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
    Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
    Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome of intravitreal dexamethasone implant for the treatment of ranibizumab-resistant macular edema secondary to retinal vein occlusion.
    Manousaridis K; Peter S; Mennel S
    Int Ophthalmol; 2017 Feb; 37(1):47-53. PubMed ID: 27043320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravitreal Dexamethasone Implant for Treatment of Sarcoidosis-Related Uveitis.
    Kim M; Kim SA; Park W; Kim RY; Park YH
    Adv Ther; 2019 Aug; 36(8):2137-2146. PubMed ID: 31140122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolution of vitreomacular traction following the use of the dexamethasone intravitreal implant (Ozurdex) in the treatment of macular edema secondary to central retinal vein occlusion.
    Bakri SJ; Omar AF
    J Ocul Pharmacol Ther; 2012 Oct; 28(5):547-9. PubMed ID: 22537269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recalcitrant macular edema after intravitreal bevacizumab is responsive to an intravitreal dexamethasone implant in retinal vein occlusion.
    Sharareh B; Gallemore R; Taban M; Onishi S; Wallsh J
    Retina; 2013 Jun; 33(6):1227-31. PubMed ID: 23518900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Early efficacy of dexamethasone implant (OZURDEX
    Sarda V; Fajnkuchen F; Nghiem-Buffet S; Grenet T; Chaine G; Giocanti-Auregan A
    J Fr Ophtalmol; 2017 May; 40(5):408-413. PubMed ID: 28336283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.